NCT03919617: A trial that was reported late by University of California, San Diego
This trial has reported, although it was 173 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03919617 |
|---|---|
| Title | The Effects of a Glucagon Receptor Antagonist (GRA) on Non-Glucose Metabolic Pathways in Patients With Type 1 Diabetes (Pilot Study) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 1, 2019 |
| Completion date | July 31, 2021 |
| Required reporting date | July 31, 2022, midnight |
| Actual reporting date | Jan. 20, 2023 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 173 |